American Gastroenterological Association Endorses the IBD Clinical Decision Support Tool (CDST) Developed by the…

first_img Pinterest American Gastroenterological Association Endorses the IBD Clinical Decision Support Tool (CDST) Developed by the US IBD Health Outcomes Consortium WhatsApp By Digital AIM Web Support – February 18, 2021 VOORHEES, N.J.–(BUSINESS WIRE)–Feb 18, 2021– The American Gastroenterological Association (AGA) has officially endorsed a novel Clinical Decision Support Tool (CDST) designed for healthcare providers managing patients with IBD who need evidence-based guidance on biologic therapy selection. Creation of the web-based tool was conceived of and led by Parambir Dulai, MD, an Assistant Professor at the UC San Diego School of Medicine, and the lead investigator of the US IBD Health Outcomes Consortium, a network of leading IBD treatment centers across the country. This press release features multimedia. View the full release here: “Earning the AGA’s endorsement is important because it underlines the importance of this tool for clinicians who previously didn’t have an easy way to choose the right biologic for the right patient,” noted Dulai. “In my research over the past 10 years, the preponderance of data collected from patients indicated that a tool developed in this way could improve point of care decision-making and, ultimately, patient outcomes.” Dr. Dulai built the tool using data from pivotal Phase 3 clinical trial programs for drug development, and validated it in a large real-world data set of IBD patients from the Consortium database. Since its launch in December 2019, the CDST has been used by clinicians in over 2,300 sessions with patients across desktop and mobile devices. Available for free to practicing clinicians, new users can gain immediate access to the tool here: CDST for IBD Biologics “This new CDST, built upon Dr. Dulai’s research, will dramatically improve the way clinicians select biologics for their patients,” explains Kenny Cox, Vice President at ArcheMedX, the learning technology company overseeing the technical build. “By building a predictive model into the platform, we can better equip clinicians with critical data, like the probability of achieving clinical remission, how quickly response will be seen, and considerations for follow-up and drug concentration monitoring. Clinicians simply answer prespecified questions regarding their patient’s extent of disease, exposure to anti-TNF therapy, laboratory values, and surgical history, and at that point, the platform’s predictive modeling takes over.” The tool was launched in tandem with a broader national education initiative supported by an independent educational grant from Takeda Pharmaceuticals U.S.A., Inc., and developed by RMEI Medical Education, an accredited provider of continuing education. Focused on clinicians practicing in gastroenterology and primary care, over 4,000 clinician learners have participated in the educational content to date. “Why this is important to patients with IBD might seem obvious,” said Sherri Kramer, MD, Senior Medical Director at RMEI, “since clinicians who receive IBD-related training and education, tailored to specific drivers of educational need, tend to improve the care they deliver to their patients. Our goal at RMEI is to improve their skills at assessing risk of IBD disease complications and implementing early and effective therapy.” Available for free to practicing clinicians, the accredited education activities in this initiative are available at: CE Curriculum Landing Page About the AGA Institute The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to more than 16,000 members from around the globe who are involved in all aspects of the science, practice, and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. For more information, visit About ArcheMedX ArcheMedX helps life sciences, healthcare organizations, medical education companies, and medical associations to better equip, evaluate, and predict clinician and team performance. Our flagship product, Ready, uses behavioral science to improve how individuals learn and retain information, leading to accelerated development and adoption of new clinical treatments and best practices. For more information, visit About RMEI Medical Education RMEI Medical Education, LLC (RMEI), founded in 2005, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The mission of RMEI is to create sustainable evidence-driven change in healthcare delivery through independent educational interventions that engage the multidisciplinary healthcare team and patients at the global, national, and local level, demonstrating real-world results through data analytics. For more information, visit View source version on Dave Clausen, 856-672-3152,[email protected] KEYWORD: NEW JERSEY UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: SOFTWARE RESEARCH MANAGED CARE PHARMACEUTICAL TECHNOLOGY CONTINUING EDUCATION CLINICAL TRIALS SCIENCE NURSING PRACTICE MANAGEMENT HEALTH SOURCE: RMEI Medical Education, LLC Copyright Business Wire 2021. PUB: 02/18/2021 10:45 AM/DISC: 02/18/2021 10:45 AM Twitter Pinterest Facebookcenter_img TAGS  Facebook Twitter Local NewsBusiness WhatsApp Previous articleSabonis, Brogdon lead Pacers past Timberwolves 134-128 in OTNext articleGrupo de Veículos da Eaton Lança Projeto, Desenvolvimento e Fabricação de Sistemas de Engrenagens E-Drive para Veículos Elétricos Digital AIM Web Supportlast_img read more

Jazz guard Mike Conley to compete in NBA H-O-R-S-E competition on ESPN

first_img Written by FacebookTwitterLinkedInEmailJazz guard Mike Conley is one of eight players or former players that will take part in the NBA’s online H-O-R-S-E competition.Current NBA players that are participating include Conley, Oklahoma City guard Chris Paul, Atlanta guard Trae Young, and Chicago forward Zach LaVine. There are two former NBA players competing, Chauncey Billups and Paul Pierce, along with former WNBA player Tamika Catchings, and current WNBA player Allie Quigley of the Chicago Sky.The quarterfinal round will be played Sunday on ESPN from 5-7 pm Mountain Time. The matchups for the quarterfinals feature Trae Young vs. Chauncey Billups, Mike Conley vs. Tamika Catchings, Zach LaVine vs. Paul Pierce, and Chris Paul vs. Allie Quigley.Players will be filmed competing at home locations on indoor or outdoor courts and compete shot for shot. The title sponsor, State Farm, will donate $200,000 to coronavirus relief efforts.The semifinals and championship for the competition will take place Thursday, April 16 starting at 7 pm Mountain Time on ESPN. Tags: Allie Quigley/Chauncey Billups/Chris Paul/HORSE Competition/Mike Conley/NBA/Paul Pierce/Tamika Catchings/Trae Young/Utah Jazz/Zach LaVine Robert Lovell April 10, 2020 /Coronavirus (COVID-19) related news and sports stories, Sports News – Local Jazz guard Mike Conley to compete in NBA H-O-R-S-E competition on ESPNlast_img read more